Acceptance and commitment therapy for HIV-positive men
Evaluation of the Effectiveness of Acceptance and Commitment Therapy for General Mental Health Concerns in HIV-Positive Men
NA · University of Alabama at Birmingham · NCT06625437
This study is testing whether acceptance and commitment therapy can help improve mental health and reduce stress for men living with HIV.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 24 (estimated) |
| Ages | 18 Years and up |
| Sex | Male |
| Sponsor | University of Alabama at Birmingham (other) |
| Locations | 1 site (Birmingham, Alabama) |
| Trial ID | NCT06625437 on ClinicalTrials.gov |
What this trial studies
This study examines the feasibility and effectiveness of acceptance and commitment therapy (ACT), a form of cognitive-behavioral therapy, aimed at addressing mental health concerns in HIV-positive men. Participants will engage in therapeutic sessions designed to improve their mental well-being and cope with stress and anxiety related to their condition. The study will assess both the practical implementation of ACT and its impact on participants' mental health outcomes.
Who should consider this trial
Good fit: Ideal candidates are men aged 18 and older who have been diagnosed with HIV.
Not a fit: Patients who have engaged in self-harm, have active suicidal plans, or are currently diagnosed with eating disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this therapy could significantly improve the mental health and quality of life for HIV-positive men.
How similar studies have performed: Other studies have shown promise in using acceptance and commitment therapy for various mental health issues, suggesting potential success in this approach for HIV-positive individuals.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * identify as a man * be at least 18 years old * has been diagnosed with HIV by a healthcare professional Exclusion Criteria: * has engaged in self-harm within the last three months * has attempted suicide within the last year * has had an active plan to attempt suicide within the last 30 days * is currently diagnosed with any eating disorder * has experienced hallucinations or delusions within the last 30 days * has used narcotics within the last 7 days (heroin, meth, crack cocaine, opioids)
Where this trial is running
Birmingham, Alabama
- University of Alabama at Birmingham — Birmingham, Alabama, United States (RECRUITING)
Study contacts
- Principal investigator: Nicholas Borgogna, PhD — University of Alabama at Birmingham
- Study coordinator: Nicholas Borgogna, PhD
- Email: borgogna@uab.edu
- Phone: (205) 934-3850
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Stress, Anxiety, Mental Disorder, Distress-based Psychopathology